IRIDEX Corporation (IRIX) Financial Statements (2024 and earlier)

Company Profile

Business Address 1212 TERRA BELLA AVE
MOUNTAIN VIEW, CA 94043
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,0347,9819,82111,04813,92215,856
Cash and cash equivalents7,0347,9819,82111,04813,92215,856
Receivables6,7276,1096,41710,7599,7689,744
Inventory, net of allowances, customer advances and progress billings9,90610,11811,12911,24110,60810,765
Inventory9,90610,11811,12911,24110,60810,765
Other undisclosed current assets3,7833,1343,5981,6501,4681,984
Total current assets:27,45027,34230,96534,69835,76638,349
Noncurrent Assets
Operating lease, right-of-use asset2,6322,7891,1381,4231,6651,862
Property, plant and equipment351524397449462435
Intangible assets, net (including goodwill)2,6072,6912,7752,8592,9423,026
Goodwill965965965965965965
Intangible assets, net (excluding goodwill)1,6421,7261,8101,8941,9772,061
Other noncurrent assets1,3961,6031,6641,5511,4551,287
Total noncurrent assets:6,9867,6075,9746,2826,5246,610
TOTAL ASSETS:34,43634,94936,93940,98042,29044,959
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,4953,7815,5395,6785,4069,106
Employee-related liabilities2,862
Accounts payable4,4992,6104,1443,5463,8584,539
Accrued liabilities1,9961,1711,3952,1321,5481,705
Deferred revenue2,4042,2392,3102,4242,4112,431
Other liabilities925886825882968841
Due to related parties12315101
Other undisclosed current liabilities3,1503,4423,5614,0553,6531,154
Total current liabilities:12,97410,34812,23513,16212,45313,633
Noncurrent Liabilities
Long-term debt and lease obligation:      961
Liabilities, other than long-term debt11,94012,53711,25411,93412,60612,290
Accounts payable and accrued liabilities 13813813812410691
Deferred revenue10,02510,47210,88111,31211,74212,172
Other liabilities262625262627
Operating lease, liability1,7511,901210472732961
Total noncurrent liabilities:11,94012,53711,25411,93412,60613,251
Total liabilities:24,91422,88523,48925,09625,05926,884
Equity
Equity, attributable to parent9,52212,06413,45015,88417,23118,075
Common stock172172171169169169
Additional paid in capital88,44487,99387,64787,31286,80286,286
Accumulated other comprehensive income (loss)(52)(19)(40)(35)(24)188
Accumulated deficit(79,042)(76,082)(74,328)(71,562)(69,716)(68,568)
Total equity:9,52212,06413,45015,88417,23118,075
TOTAL LIABILITIES AND EQUITY:34,43634,94936,93940,98042,29044,959

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues12,45812,85012,85513,70615,19514,635
Cost of revenue(7,573)(7,229)(7,492)(7,768)(8,531)(8,175)
Gross profit:4,8855,6215,3635,9386,6646,460
Operating expenses(7,966)(7,309)(8,257)(8,282)(8,074)(8,155)
Operating loss:(3,081)(1,688)(2,894)(2,344)(1,410)(1,695)
Nonoperating income (expense)181(58)138266276(58)
Loss from continuing operations before income taxes:(2,900)(1,746)(2,756)(2,078)(1,134)(1,753)
Income tax expense(60)(8)(10)(12)(14)(14)
Loss from continuing operations:(2,960)(1,754)(2,766)(2,090)(1,148)(1,767)
Loss before gain (loss) on sale of properties:(1,767)
Net loss available to common stockholders, diluted:(2,960)(1,754)(2,766)(2,090)(1,148)(1,767)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net loss:(2,960)(1,754)(2,766)(2,090)(1,148)(1,767)
Other comprehensive income (loss)(33)21(5)(11)(212)59
Comprehensive loss, net of tax, attributable to parent:(2,993)(1,733)(2,771)(2,101)(1,360)(1,708)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: